Key result
p21WAF1/CIP1 expression was upregulated 4.15-fold in spontaneously hypertensive rats (P=0.002), and its modulation demonstrated that p21 facilitates the development of cardiac hypertrophy.
The cyclin-dependent kinase inhibitor p21WAF1/CIP1 facilitates cardiac hypertrophy, and its inhibition attenuates hypertrophic growth in preclinical models.
Answers are grounded in this paper and cite their sources.
p21 changes in hypertensive LV models warrant no clinical action; leaves open causal role in hypertrophy.
BACKGROUND/AIMS: Adult cardiomyocytes can re-enter cell cycle as stimulated by prohypertrophic factors although they withdraw from cell cycle soon after birth. p21WAF1/CIP1, a cyclin-dependent kinase inhibitor, has been implicated in cardiac hypertrophy, however, its precise contribution to this process remains largely unclear. METHODS: The gene expression profile in left ventricle (LV) of spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats was determined using quantitative PCR array and verified by real-time PCR and Western blotting. Hypertrophic response of H9c2 cells and neonatal rat ventricular myocytes (NRVM) were induced by angiotensin II (1 µmol/L). Cardiac hypertrophy of mice was elicited by isoproterenol (ISO) infusion (40 mg/kg per day for 14 days). p21-adenovirus and p21-siRNA were employed to transfect NRVM, and sterigmatocystin (STE, 3 mg/kg, ip, qd) was used to inhibit p21 activity. mRNA and protein expression levels of α- and β-myosin heavy chain (MHC), p21WAF1/CIP1, calcineurin (CaN) and atrial natriuretic peptide (ANP) were assayed by realtime PCR and WB, respectively. RESULTS: Sixteen genes showed two-fold or greater changes between SHR and WKY rats, in which the expression of p21WAF1/CIP1 was upregulated by 4.15-fold (P=0.002) and reversed by losartan. Surface area, protein content, mRNA and protein expressions of β-MHC, ANP and p21WAF1/CIP1 in H9c2 cells treated with AngII elevated significantly compared with control group. p21-Ad transfection markedly increased the surface area and β-MHC mRNA expression of normal NRVMs, and p21-siRNA transfection decreased them in AngII-treated NRVMs. STE treatment decreased HW/BW and cross-sectional area, expression levels of β-MHC, ANP and p21 significantly in ISO-treated mice. CONCLUSION: Our findings suggest that p21 facilitates the development of cardiac hypertrophy, and regulating the expression of p21 may be an approach to attenuate hypertrophic growth of cardiomyocytes.
No takes yet. Share an insight, caveat, or question.
Tong et al. (2017) studied Cardiac hypertrophy. p21WAF1/CIP1 modulation vs. Control was evaluated on Gene expression and hypertrophic response (4.15-fold upregulation, p=0.002). p21WAF1/CIP1 expression was upregulated 4.15-fold in spontaneously hypertensive rats (P=0.002), and its modulation demonstrated that p21 facilitates the development of cardiac hypertrophy.
Synapse has enriched 10 related papers. Consider them for comparative context: